Skip to content
HCN Grants Est. 2026
No. HT942526SCIRPCTRA · Defense Health Agency Contracting Activity - DHACA
Open

DoW Spinal Cord Injury, Clinical Translation Research Award

Dealbreakers No cost share required Audit: not stated Reimbursement-only: not stated

At a glance

This program funds high-impact clinical research on spinal cord injury that needs extra preliminary work, such as feasibility, pilot, or optimization studies, to prepare for larger clinical trials or implementation. It is open to eligible U.S. Department of War organizations and affiliated investigators, including foreign or domestic, for-profit or nonprofit, and public or private entities; cost sharing is not required. The program expects to fund about 3 awards with about $6.12 million total, with up to $2.0 million per award for a single PI or $2.16 million per award under the Early-Career Partnership Option. Awards last up to 3 years. Research must address at least one stated priority area, and applications must name at least two spinal cord injury community partners.

AI-generated summary — verify against the announcement

What it funds

  • Science and Technology and other Research and Development
  • Research & Discovery
  • Patients & People with Health Conditions
  • Biomedical & Disease Research
Official description from grants.gov

Summary: The fiscal year 2026 (FY26) Spinal Cord Injury Research Program (SCIRP) Clinical Translation Research Award (CTRA) supports high-impact, new, or emerging clinical research that requires additional preliminary studies, such as feasibility, pilot, or optimization, to prepare for future larger-scale clinical trials or implementation. Primary objectives of this mechanism include: • Accelerating the translation of current and emerging techniques or interventions into clinical use by addressing specific barrier(s) to clinical success for the purpose of de-risking or informing the design of definitive trials. • Identifying the most effective diagnosis, treatment and rehabilitation options to support critical decision-making for patients, clinicians, care partners and policymakers. Distinctive Features: • This funding opportunity contains an Early-Career Partnership Option, which allows for two principal investigators (PIs). If this option is selected, at least one of the named PIs must be an early-career investigator. Be advised, all associated applications for a research project may be withdrawn if the initiating or partnering application is rejected or administratively withdrawn. • Applications to this funding opportunity must name at least two spinal cord injury (SCI) community partners who will provide advice and consultation throughout the planning and implementation of the research project.

Who can apply

  • Unrestricted
Geographic restriction None found in the announcement — likely nationwide